Seeing Is Believing

Currently out of the existing stock ratings of Carter Gould, 186 are a BUY (53.76%), 132 are a HOLD (38.15%), 28 are a SELL (8.09%).
Analyst Carter Gould, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 73.67% that have a potential upside of 27.78% achieved within 286 days. Previously, Carter Gould worked at BARCLAYS.
Carter Gould’s has documented 693 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Basic Materials, Technology sectors.
Most recent stock forecast was given on AMGN, Amgen at 08-Sep-2026.
Analyst best performing recommendations are on APLT (APPLIED THERAPEUTICS).
The best stock recommendation documented was for APLT (APPLIED THERAPEUTICS) at 3/21/2022. The price target of $2.5 was fulfilled within 3 days with a profit of $0.67 (36.61%) receiving and performance score of 122.04.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2026
$315
$50.66 (19.16%)
$265
20 days ago
(10-Sep-2026)
6/7 (85.71%)
$60 (23.53%)
115
Buy Since 12-Sep-2025
$303
$38.66 (14.63%)
$298
1 months 10 days ago
(20-Aug-2026)
2/12 (16.67%)
$41.17 (15.72%)
35
Buy Since 09-Dec-2021
$300
$35.66 (13.49%)
$295
1 months 13 days ago
(17-Aug-2026)
14/16 (87.5%)
$49.67 (19.84%)
506
Hold Since 13-Aug-2026
$300
$35.66 (13.49%)
1 months 17 days ago
(13-Aug-2026)
1/2 (50%)
$49.18 (19.61%)
115
Buy Since 23-Jan-2023
$260
$-4.34 (-1.64%)
$235
1 months 20 days ago
(10-Aug-2026)
9/9 (100%)
$12.03 (4.85%)
133
Which stock is Carter Gould most bullish on?
Which stock is Carter Gould most reserved on?
What Year was the first public recommendation made by Carter Gould?